Evidence review
GLP-1s and fertility: trying to conceive
Planning pregnancy with a GLP-1? Drug-specific timing, tirzepatide contraception precautions, and the limits of fertility evidence.
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
The most important thing, first
If there is one thing to take from this page, it is this: plan a medication-specific transition before trying to conceive. GLP-1 weight-loss treatment is not recommended during pregnancy; diabetes or other conditions also need a pregnancy-appropriate treatment plan. Timing and contraception deserve a conversation with your prescriber before a pregnancy attempt7,8,9.
Why you stop before, not during
For semaglutide, Wegovy and Ozempic labels advise stopping at least two months before a planned pregnancy because of the long half-life8,9. Do not apply that interval to every GLP-1 medicine: review your exact product, indication and other medicines with your clinician. If diabetes treatment is needed, agree on an alternative plan rather than going without glucose care. Coming off a weight-loss medicine is part of pregnancy planning, not a substitute for that wider review.
The part that comes after you stop
A 2025 observational study matched 448 exposed pregnancies with 1,344 controls in its weight-gain analysis. Exposure meant a GLP-1 prescription within three years before conception or up to 90 days after. Pregnancy weight gain averaged 13.7 versus 10.5 kg. Separate obstetric analyses reported higher rates of some outcomes, but several associations weakened after additional adjustment. The investigators matched on prepregnancy BMI; obesity in the exposed group does not by itself explain the differences. Other unmeasured differences between the groups may remain, and the study cannot establish cause1. Ask your clinician how appetite, weight and glucose will be monitored after stopping.
What if a pregnancy happens unexpectedly?
First — breathe. Contact your prescriber and obstetric clinician promptly with the medicine, indication and last dose. Zepbound and Wegovy used for weight loss should be stopped when pregnancy is recognized; Ozempic for diabetes needs an urgent benefit-risk discussion and a pregnancy-appropriate treatment plan7,8,9. A large observational study in women with type 2 diabetes found no clear increase in major birth defects with early GLP-1 exposure compared with insulin. That is reassuring, but does not establish safety for an individual pregnancy or continued use2.
The birth-control detail nobody warns you about
With tirzepatide, the label advises people using oral hormonal contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and four weeks after every dose increase. Non-oral hormonal contraception should not be affected7. Discuss the method with your clinician. Taking a weight-loss medicine does not mean you cannot get pregnant.
The flip side: GLP-1 medicines and improved fertility
Weight loss and improved metabolic health may support ovulation, particularly with PCOS3. Semaglutide has demonstrated weight loss in adults with overweight or obesity, but that trial was not a fertility trial5. Reviews describe GLP-1 medicines as promising before pregnancy in selected women with obesity and PCOS; evidence for fertility outcomes remains limited and does not establish them as a fertility treatment for everyone4,6. If a GLP-1 fits your medical needs, discuss contraception and the medication-specific transition before trying to conceive.
How to actually plan this
The clean version of a plan looks like: talk with your clinician about your timeline, agree on when to stop the medication and how long to wait, sort out reliable contraception for the in-between (especially on tirzepatide), and agree on which medicines to stop and which pregnancy-appropriate treatments to continue. Reviews of medical therapy for fertility keep landing on the same point — any plan like this is only as good as the clinician steering it for your body4, so lean on that relationship. If you are still deciding whether a GLP-1 fits you at all, is GLP-1 right for me? is a gentle place to start.
A warm next step
If you are weighing a GLP-1 with motherhood on the horizon, the right first move is a clinician who will map the stop-and-try timeline with you. If PCOS is part of your fertility story, can GLP-1 help PCOS? is worth reading next. You are allowed to plan this carefully and kindly. — Camila
Frequently asked questions
How long before trying to conceive should I stop a GLP-1?
Wegovy and Ozempic labels advise stopping semaglutide at least two months before a planned pregnancy. Do not apply that interval to every GLP-1. Ask your clinician for the timing for your exact medicine and indication, and an alternative plan if you need diabetes treatment.
I got pregnant while on a GLP-1 — should I panic?
Early-exposure data are reassuring but cannot establish safety for your pregnancy. Contact your prescriber and obstetric clinician promptly. Zepbound and Wegovy used for weight loss should be stopped when pregnancy is recognized; Ozempic for diabetes needs an urgent benefit-risk review and pregnancy-appropriate treatment plan.
Can a GLP-1 make my birth control less effective?
Tirzepatide may reduce the effectiveness of oral hormonal contraceptives. Its label advises switching to a non-oral method or adding a barrier method for four weeks after starting and four weeks after every dose increase. Discuss the method with your clinician; non-oral hormonal contraception should not be affected.
Can a GLP-1 actually help me get pregnant?
Indirectly, for some women. Weight loss and better metabolic health may support ovulation, especially with PCOS. Evidence for GLP-1 medicines as fertility treatment remains limited. They are not a pregnancy treatment: discuss eligibility, contraception and a medication-specific transition with your clinician before trying to conceive.
Where this leaves you
References
- Maya J, Pant D, Fu Y, et al. (2025). Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation. JAMA. https://pubmed.ncbi.nlm.nih.gov/41284263/
- Cesta CE, Rotem R, Bateman BT, et al. (2024). Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/38079178/
- Ruiz-González D, Cavero-Redondo I, Hernández-Martínez A, et al. (2024). Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis. Human Reproduction Update. https://pubmed.ncbi.nlm.nih.gov/38627233/
- Duah J, Seifer DB. (2025). Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reproductive Biology and Endocrinology. https://pubmed.ncbi.nlm.nih.gov/39762910/
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Cena H, Chiovato L, Nappi RE. (2020). Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. The Journal of Clinical Endocrinology and Metabolism. https://pubmed.ncbi.nlm.nih.gov/32442310/
- Eli Lilly and Company (2026). Zepbound — Prescribing Information, sections 8.1 Pregnancy and 8.3 Females and Males of Reproductive Potential. DailyMed / prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Novo Nordisk Inc. (2026). Ozempic — Prescribing Information, sections 8.1 Pregnancy and 8.3 Females and Males of Reproductive Potential. DailyMed / prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Novo Nordisk Inc. (2026). Wegovy — Prescribing Information, sections 8.1 Pregnancy and 8.3 Females and Males of Reproductive Potential. DailyMed / prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Friendly information, not a prescription. Everything on MamaGLP is here to help you understand your options and ask better questions — it is not a diagnosis, not a treatment plan, and not a nudge to start or stop anything. Only a licensed healthcare professional who knows your history and your goals can tell you what is right for you, so please talk with one before acting on a single word of this.
Keep reading
Ozempic and metformin: the same, or taken together?
Not the same, and almost always taken together. What each one does, what happened in a trial of women with PCOS, and what the Ozempic label says.
ReadPeriod changes on a GLP-1 and birth control
Cycles get heavier, lighter or unpredictable, and ovulation can return. Plus the interaction that applies to tirzepatide and does not apply to semaglutide.
ReadGLP-1s and Pregnancy: What the Data Actually Shows
GLP-1s and pregnancy: label advice by treatment indication, planning before conception, and what early-exposure research can and cannot tell you.
ReadPostpartum body changes and GLP-1s: a careful guide
A warm, careful guide to your postpartum body and GLP-1s — the real timing questions, the nursing caution, and why patience is on your side.
ReadBreast and nursing changes on a GLP-1: what to know
A gentle, cited guide to breast changes and breastfeeding on a GLP-1 — what the lactation evidence says, and why your clinician leads.
ReadCan a GLP-1 help with PCOS? An honest guide
Do GLP-1s like semaglutide help with PCOS? A kind, well-cited look at the evidence on weight, cycles, and moms.
ReadGLP-1s for endometriosis: what we actually know
Can GLP-1s help with endometriosis? An honest, cited look at the thin, emerging evidence — with no hype.
ReadIs a GLP-1 right for me? A gentle explainer for moms
Who may be considered for a GLP-1, which health and pregnancy questions matter, and what to ask before agreeing to treatment or payment.
ReadDo GLP-1s cause breast cancer?
Pooled trials covering more than 94,000 people find no increased breast cancer risk on GLP-1s — and one counting error explains where the fear started.
ReadAfter gestational diabetes: GLP-1 follow-up
Had gestational diabetes? Postpartum glucose testing comes before a GLP-1 decision. Understand follow-up, treatment eligibility and family planning.
ReadTirzepatide and the birth-control pill
Zepbound and Mounjaro can reduce oral hormonal contraceptive effectiveness. The four-week windows, non-oral methods and questions to ask before a dose change.
Read